Comments for Cel-Sci's H1N1 Program is "Moving So Fast" at http://www.biomedreports.com , comment 1 to 13 out of 13 comments http://www.biomedreports.com Wed, 08 Feb 2012 18:11:37 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1273 Mr. Garza, I was wondering if you had gathered any updated information regarding Cel-Sci's results/work with LEAPs on malaria with the US Navy studies. Did Dr. Zimmerman mention anything about this area of study? - Mike L Fri, 30 Oct 2009 05:07:09 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1221 Guess what! A dilution is coming before CVMs H1N1 resluts. Garza we saw this in HEB and CTIC! We really do not like to get crushed again. I have a faith in your report BUT suspicious about these pharamas. - Navroz Tue, 20 Oct 2009 08:52:18 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1220 Very exciting developments for Cel-Sci.... I believe they're working on some very beneficial immunotherapies.... Because they've been working on their technology for quite a few years.... investors are seeking for tangible near-term successes (i.e. major partnerships, commencement of PIII for Multikine, successful results in H1N1 clinical trial, etc.). It's not good enough to be working on potentially blockbuster treatments.... we need to see results... with a steady progression towards commercialization. I'm long CVM because I beleive in what they're doing.... but repeating that oft-repeated line from Jerry Mcguire.... "Show me the Money!" - markbuti Tue, 20 Oct 2009 08:20:22 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1219 Truu, did you continue to read the sec filings, on page 8 or 9, I had stock in this company until I read the sec filings, I sold all my stock, I was skeptical before the sec filings. I wanted to believe, so I did. I was skeptical before and it confirmed I had made a mistake. I my opinion. - Duaine Swarthout Tue, 20 Oct 2009 08:15:26 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1218 Investor Soup's report was incomplete. See SEC filings. - Roy Malis Tue, 20 Oct 2009 06:34:22 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1217 Jason and Jo Sauza asked questions about funding for the Multikine Phase III trial: "Does CVM have the funds to finance the Phase III trials or are they currently seeking funding?" Let me share with you the answer provided BY THE COMPANY in YESTERDAY'S SEC Filing (October 19, 2009): " Since CEL-SCI recently obtained substantial financing, CEL-SCI is moving forward rapidly to launch its global Phase III clinical trial." This is THE MOST RECENT information provided by the company, and represents a very distinct change in wording from previous SEC filings. This comes from Page 5 of this link (http://www.sec.gov/Archives/edgar/data/725363/000100487809000233/0001004878-09-000233.txt) and appears in the 4th paragraph on Page 5. Scroll down until you find it. In my opinion, there could be some VERY big things in store for CVM investors very soon. Thank you Mr. Garza for your continued research and for helping people learn about the amazing things this company is doing. - truu Tue, 20 Oct 2009 06:09:09 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1216 Hello guys, Keep up the good works and keep us posting I like cvm and dr.Zimmerman specially the LEAPS technology. CVM go!go!go!CVM go!I am going to stay investing on CVM!such a great company and they are the future of the world in term of medication. Silvestre Marcelo - silvestre marcelo Tue, 20 Oct 2009 04:06:41 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1215 I like what you guys are doing, and think this is a huge step towards many cures, the research that you and your company have done will save/better many lives, its just a matter of time till everyone knows about your break through, keep up the good work. - josh Tue, 20 Oct 2009 03:18:46 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1213 My question is, why is Cel-Sci today stating that it won't begin the Phase III Trial of Multikine until they raise more money when only a few weeks ago they stated that they had raised the money necessary for the trial, $20 million, by selling almost 15 million shares of CVM stock? That is a worrisome contradiction....are they going to apply the $20 million to the trial or not; OR did they not receive that $20 million after all......? Another point is that they have been saying for many months now that the validation of their manufacturing facility was "soon" to be finalized??? I am a share holder and would really appreciate some clarification. - Jo Sauza Tue, 20 Oct 2009 02:04:39 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1211 Very good report. We have much to be hopeful for while being careful not to make false claims. The gathering of data, the analysis of the data all serve to make better treatments in the future. Good science takes a long time. Every once in awhile, when we are working toward a goal, something that is really useful for society takes place. There must be continued research into the basic sciences. Research takes money. That's the job of the investor, to help fund the science that is needed. The scientist today needs to report advances in terms that investors understand, and that is what Dr. Zimmerman did for me today. - nick77 Tue, 20 Oct 2009 01:56:53 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1209 This is good news and I'm long on CVM but now I'm confused about it's current funding for Mulikine. On previous press reports and news articles it was stated that with current interest and private investments of almost 20 million CVM is fully funded to commence and get through phase III trials. Today an article was released by Investor Soup stating "Additionally, the Company obtained new financing of $5,845,241 in June of 2009, net of financing costs of $339,329. The Company is currently working toward a transaction that will finance its phase III clinical trial of Multikine". Does CVM have the funds to finance the Phase III trials or are they currently seeking funding? I'm sure I can't be the only investor that caught on to this statement and are now questioning the validity of previous statements. Any insight that you can provide will be appreciated. - Jason Tue, 20 Oct 2009 01:33:12 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1208 I have a full faith in Cell-Sci Technology (AMEX:CVM) which is going to develop the 21st Centuary Medicine for devastating human diseases for betterment for our Society. Their techology not only "KILL" the infected area but also inhances the protection by activating our Immune System to cure the DISEASE for ever. Wish a good luck for their time and effort for developing such Technolgy. - LS Chaturvedi Tue, 20 Oct 2009 01:11:49 +0100 http://www.biomedreports.com/2009102013910/h1n1-program-is-qmoving-so-fastq.html#comment-1206 Way to go Dr Z!!!! LEAPS is the most exciting and promising system for using the immune system in disease treatment ever, you must be very pleased to see your baby bearing fruit! And none too soon! - Bill Hahn Mon, 19 Oct 2009 23:47:48 +0100